Mostrando 1 - 20 Resultados de 118 Para Buscar '"Leishmaniasis"', tiempo de consulta: 0.13s Limitar resultados
  1. 1
    por Sundar, Shyam
    Publicado 2015
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral leishmaniasis
  2. 2
    por Chakravarty, Jaya, Sundar, Shyam
    Publicado 2010
    “…The treatment options of leishmaniasis are limited and far from satisfactory. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Drug Resistance in Leishmaniasis
  3. 3
    “…To identify factors associated with incidence of visceral leishmaniasis (VL), we surveyed 13,416 households in Bihar State, India. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral Leishmaniasis in Rural Bihar, India
  4. 4
    “…BACKGROUND: With widespread resistance to antimonials in Visceral Leishmaniasis (VL) in the Indian subcontinent, Miltefosine (MIL) has been introduced as the first line therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Drug Susceptibility in Leishmania Isolates Following Miltefosine Treatment in Cases of Visceral Leishmaniasis and Post Kala-Azar Dermal Leishmaniasis
  5. 5
    por Sundar, Shyam, Chakravarty, Jaya
    Publicado 2010
    “…Liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). It is the treatment of choice for immunocompetent patients in the Mediterranean region and the preferred drug for HIV/VL co-infection. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Liposomal Amphotericin B and Leishmaniasis: Dose and Response
  6. 6
    por Singh, Om Prakash, Sundar, Shyam
    Publicado 2015
    “…Visceral leishmaniasis (VL) is the most devastating parasitic infection worldwide causing high morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era
  7. 7
    “…Here, we examined the potential of modulating glucocorticoid-induced TNF receptor-related protein (GITR) on T cells to improve anti-parasitic immunity in blood and spleen tissue from visceral leishmaniasis (VL) patients infected with Leishmania donovani. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Combined Immune Therapy for the Treatment of Visceral Leishmaniasis
  8. 8
    “…Background: There is a recognized need for an improved diagnostic test to assess post-chemotherapeutic treatment outcome in visceral leishmaniasis (VL) and to diagnose post kala-azar dermal leishmaniasis (PKDL). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis
  9. 9
    “…BACKGROUND: In the Indian subcontinent, about 200 million people are at risk of developing visceral leishmaniasis (VL). In 2005, the governments of India, Nepal and Bangladesh started the first regional VL elimination program with the aim to reduce the annual incidence to less than 1 per 10,000 by 2015. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control
  10. 10
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Glycosylation of Erythrocyte Spectrin and Its Modification in Visceral Leishmaniasis
  11. 11
    “…Leishmania donovani causes visceral leishmaniasis (VL), the second most deadly vector-borne parasitic disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
  12. 12
    “…Suman Rijal and colleagues highlight lessons from a regional collaboration to eliminate visceral leishmaniasis and identify priorities for the post-elimination plan…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Eliminating visceral leishmaniasis in South Asia: the road ahead
  13. 13
    “…BACKGROUND: Visceral leishmaniasis (VL) is a deadly parasitic diseases caused by Leishmania donovani; it is a major health problem in many countries. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparative proteomics and glycoproteomics of plasma proteins in Indian visceral leishmaniasis
  14. 14
    “…Visceral leishmaniasis (VL) remains an important public health issue worldwide causing substantial morbidity and mortality. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination
  15. 15
    por Sundar, Shyam, Olliaro, Piero L
    Publicado 2007
    “…Visceral leishmaniasis (VL) is a life-threatening disease. Traditional treatment with pentavalent antimony injections has become ineffective in the area with the world’s highest prevalence of disease (North Bihar, India) and is becoming less effective elsewhere as well. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Miltefosine in the treatment of leishmaniasis: Clinical evidence for informed clinical risk management
  16. 16
    “…BACKGROUND: Visceral leishmaniasis is a systemic parasitic disease that is fatal unless treated. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
  17. 17
    “…BACKGROUND: Visceral Leishmaniasis (VL) is a vector-borne disease transmitted by Phlebotomus argentipes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008
  18. 18
    “…BACKGROUND: PCR based diagnosis for Visceral Leishmaniasis (VL), despite numerous published primers, remains far from being applied in the field. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Diagnosis of Indian Visceral Leishmaniasis by Nucleic Acid Detection Using PCR
  19. 19
    “…INTRODUCTION: Studies employing serological, DTH or conventional PCR techniques suggest a vast proportion of Leishmania infected individuals living in regions endemic for Visceral Leishmaniasis (VL) remain asymptomatic. This study was designed to assess whether quantitative PCR (qPCR) can be used for detection of asymptomatic or early Leishmania donovani infection and as a predictor of progression to symptomatic disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Quantitative PCR in Epidemiology for Early Detection of Visceral Leishmaniasis Cases in India
  20. 20
    “…Long regimens for the treatment of post-kala-azar dermal leishmaniasis (PKDL) result in noncompliance. A safe, effective, and acceptable regimen for the treatment of PKDL is still to be developed. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Efficacy and Safety of Miltefosine in Treatment of Post-Kala-Azar Dermal Leishmaniasis
Herramientas de búsqueda: RSS